Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer.
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to define the optimal management of localised transitional cell
carcinoma (TCC) of the urinary bladder. The main objective is to evaluate whether
chemoradiation is superior to radiotherapy alone.
Phase:
Phase 3
Details
Lead Sponsor:
Trans Tasman Radiation Oncology Group Trans-Tasman Radiation Oncology Group (TROG)
Collaborator:
National Health and Medical Research Council, Australia